Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Marie Kappelgaard

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Hormone Research in Paediatrics|February 15, 2014
The impact of long-term growth hormone treatment on metabolic parameters in Japanese patients with short stature born small for gestational ageAnne-Marie Kappelgaard, Fumiaki Kiyomi, Reiko Horikawa, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 22, 2011
Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patientsAnne-Marie Kappelgaard, Søren Mikkelsen, Thomas Kamp Knudsen, et al.
Expert Review of Medical Devices|December 7, 2013
Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to payUdo Meinhardt, Urs Eiholzer, Lisa Seitz, et al.
Medical Devices (Auckland, N.Z.)|August 16, 2013
Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysisRichard F Pollock, Yujun Qian, Tami Wisniewski, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 21, 2019
What is the evidence for beneficial effects of growth hormone treatment beyond height in short children born small for gestational age? A review of published literatureDavid Dunger, Feyza Darendeliler, Nurgun Kandemir, et al.
Hormone Research in Paediatrics|July 3, 2013
Prepubertal children with growth hormone deficiency treated for four years with growth hormone experience dose-dependent increase in height, but not in the rate of puberty initiationAlan D Rogol, Pinchas Cohen, Wayne Weng, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safetyPinchas Cohen, George M Bright, Alan D Rogol, et al.
Clinical Endocrinology|January 17, 2014
Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerationsPinchas Cohen, Wayne Weng, Alan D Rogol, et al.
Clinical Therapeutics|November 25, 2010
Intuitiveness, ease of use, and preference of a prefilled growth hormone injection pen: a noninterventional, randomized, open-label, crossover, comparative usability study of three delivery devices in growth hormone-treated pediatric patientsAndreas Pfützner, Klaus Hartmann, Franziska Winter, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2010
Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short childrenPinchas Cohen, John Germak, Alan D Rogol, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Hormone Research in Paediatrics|February 15, 2014
The impact of long-term growth hormone treatment on metabolic parameters in Japanese patients with short stature born small for gestational ageAnne-Marie Kappelgaard, Fumiaki Kiyomi, Reiko Horikawa, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 22, 2011
Patient preference for a new growth hormone injection device: results of an open-label study in Japanese pediatric patientsAnne-Marie Kappelgaard, Søren Mikkelsen, Thomas Kamp Knudsen, et al.
Expert Review of Medical Devices|December 7, 2013
Parent preference in Switzerland for easy-to-use attributes of growth hormone injection devices quantified by willingness to payUdo Meinhardt, Urs Eiholzer, Lisa Seitz, et al.
Medical Devices (Auckland, N.Z.)|August 16, 2013
Product wastage from modern human growth hormone administration devices: a laboratory and computer simulation analysisRichard F Pollock, Yujun Qian, Tami Wisniewski, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|December 21, 2019
What is the evidence for beneficial effects of growth hormone treatment beyond height in short children born small for gestational age? A review of published literatureDavid Dunger, Feyza Darendeliler, Nurgun Kandemir, et al.
Hormone Research in Paediatrics|July 3, 2013
Prepubertal children with growth hormone deficiency treated for four years with growth hormone experience dose-dependent increase in height, but not in the rate of puberty initiationAlan D Rogol, Pinchas Cohen, Wayne Weng, et al.
The Journal of Clinical Endocrinology and Metabolism|January 15, 2002
Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safetyPinchas Cohen, George M Bright, Alan D Rogol, et al.
Clinical Endocrinology|January 17, 2014
Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerationsPinchas Cohen, Wayne Weng, Alan D Rogol, et al.
Clinical Therapeutics|November 25, 2010
Intuitiveness, ease of use, and preference of a prefilled growth hormone injection pen: a noninterventional, randomized, open-label, crossover, comparative usability study of three delivery devices in growth hormone-treated pediatric patientsAndreas Pfützner, Klaus Hartmann, Franziska Winter, et al.
The Journal of Clinical Endocrinology and Metabolism|March 9, 2010
Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short childrenPinchas Cohen, John Germak, Alan D Rogol, et al.
Pageof 3